These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31930459)

  • 21. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
    Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
    Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes.
    Hsu WH; Wen YW; Chen LK; Hsiao FY
    Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease.
    Lanctôt KL; O'Regan J; Schwartz Y; Swardfager W; Saleem M; Oh PI; Herrmann N
    Psychosomatics; 2014; 55(1):61-8. PubMed ID: 23993643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Nine Instruments to Calculate Anticholinergic Load in a Large Cohort of Older Outpatients: Association with Cognitive and Functional Decline, Falls, and Use of Laxatives.
    Mayer T; Meid AD; Saum KU; Brenner H; Schöttker B; Seidling HM; Haefeli WE
    Am J Geriatr Psychiatry; 2017 May; 25(5):531-540. PubMed ID: 28233606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticholinergic Activity of Psychotropic Drugs and Cognitive Impairment Among Participants Aged 45 and Over: The CONSTANCES Study.
    Ziad A; Berr C; Ruiz F; Bégaud B; Lemogne C; Goldberg M; Zins M; Mura T
    Drug Saf; 2021 May; 44(5):565-579. PubMed ID: 33575980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticholinergic effect on cognition (AEC) of drugs commonly used in older people.
    Bishara D; Harwood D; Sauer J; Taylor DM
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):650-656. PubMed ID: 27280553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults.
    Martinez AI; Abner EL; Jicha GA; Rigsby DN; Eckmann LC; Huffmyer MJ; Moga DC
    J Manag Care Spec Pharm; 2020 Apr; 26(4):520-528. PubMed ID: 32223601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hand dexterity, not handgrip strength, is associated with executive function in Japanese community-dwelling older adults: a cross-sectional study.
    Kobayashi-Cuya KE; Sakurai R; Sakuma N; Suzuki H; Yasunaga M; Ogawa S; Takebayashi T; Fujiwara Y
    BMC Geriatr; 2018 Aug; 18(1):192. PubMed ID: 30143006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between physical performance and executive function in older adults with mild cognitive impairment: gait speed and the timed "up & go" test.
    McGough EL; Kelly VE; Logsdon RG; McCurry SM; Cochrane BB; Engel JM; Teri L
    Phys Ther; 2011 Aug; 91(8):1198-207. PubMed ID: 21616934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of medications with anticholinergic properties and cognitive function in a young-old community sample.
    Low LF; Anstey KJ; Sachdev P
    Int J Geriatr Psychiatry; 2009 Jun; 24(6):578-84. PubMed ID: 19021151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
    Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
    Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term anticholinergic, benzodiazepine and Z-drug use in community-dwelling older adults: What is the impact on cognitive and neuropsychological performance?
    Dyer AH; Laird E; Hoey L; Hughes CF; McNulty H; Ward M; Strain JJ; Molloy AM; Cunningham C; McCarroll K
    Int J Geriatr Psychiatry; 2021 Nov; 36(11):1767-1777. PubMed ID: 34227695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticholinergic drug use is associated with episodic memory decline in older adults without dementia.
    Papenberg G; Bäckman L; Fratiglioni L; Laukka EJ; Fastbom J; Johnell K
    Neurobiol Aging; 2017 Jul; 55():27-32. PubMed ID: 28407520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of anticholinergic burden of medications in older adults.
    West T; Pruchnicki MC; Porter K; Emptage R
    J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of Skeletal Muscle Mass, Lower-Extremity Functioning, and Cognitive Impairment in Community-Dwelling Older People in Japan.
    Ishii H; Makizako H; Doi T; Tsutsumimoto K; Shimada H
    J Nutr Health Aging; 2019; 23(1):35-41. PubMed ID: 30569066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study.
    Sumbul-Sekerci B; Bilgic B; Pasin O; Emre M; Hanagasi HA
    Dement Geriatr Cogn Disord; 2022; 51(5):386-395. PubMed ID: 36273437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Size of the associations between anticholinergic burden tool scores and adverse outcomes in older patients.
    Lavrador M; Cabral AC; Figueiredo IV; Veríssimo MT; Castel-Branco MM; Fernandez-Llimos F
    Int J Clin Pharm; 2021 Feb; 43(1):128-136. PubMed ID: 32860598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Joshi YB; Thomas ML; Braff DL; Green MF; Gur RC; Gur RE; Nuechterlein KH; Stone WS; Greenwood TA; Lazzeroni LC; MacDonald LR; Molina JL; Nungaray JA; Radant AD; Silverman JM; Sprock J; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Swerdlow NR; Light GA
    Am J Psychiatry; 2021 Sep; 178(9):838-847. PubMed ID: 33985348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticholinergic medication burden and cognitive function in participants of the ASPREE study.
    Broder JC; Ryan J; Shah RC; Lockery JE; Orchard SG; Gilmartin-Thomas JF; Fravel MA; Owen AJ; Woods RL; Wolfe R; Storey E; Murray AM; Ernst ME
    Pharmacotherapy; 2022 Feb; 42(2):134-144. PubMed ID: 34866212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.